Evidence map›Paper›PMID 24585759›Full record

ArticleCirculation research2014

Protein kinase A-phosphorylated KV1 channels in PSD95 signaling complex contribute to the resting membrane potential and diameter of cerebral arteries.

Christopher L Moore, Piper L Nelson, Nikhil K Parelkar, Nancy J Rusch, Sung W Rhee

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Nicotine Impairs Smooth Muscle cAMP Signaling and Vascular Reactivity.Microcirculation (New York, N.Y. : 1994) · 2024
    Article
  5. Article
  6. Mechanisms of Vascular CaHandbook of experimental pharmacology · 2023
    Article
  7. Review
  8. Metoprolol ImpairsThe Journal of pharmacology and experimental therapeutics · 2021
    Article
  9. Review
  10. Article
  11. βAnnual review of pharmacology and toxicology · 2020
    Review
  12. A GeLife · 2019
    Article
  13. Molecular determinants of beta-adrenergic signaling to voltage-gated KMicrocirculation (New York, N.Y. : 1994) · 2018
    Review
  14. KMicrocirculation (New York, N.Y. : 1994) · 2018
    Review
  15. KMicrocirculation (New York, N.Y. : 1994) · 2018
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Beta1-adrenergic receptor-mediated dilation of rat cerebral artery requires Shaker-type KV1 channels on PSD95 scaffold.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Christopher L MooreFrom the Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock (C.L.M., P.L.N., N.J.R., S.W.R.); and University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City (N.K.P.).
Piper L Nelson
Nikhil K Parelkar
Nancy J Rusch
Sung W Rhee
The University of Kansas Cancer Center · US

Funding

PSD95 scaffolding of vascular K+ channels in hypertensionR01HL097107 · NHLBI · UNIV OF ARKANSAS FOR MED SCIS · PI RHEE, SUNG W · 2010 to 2014
$1.8M
NHLBI NIH HHS R01 HL097107
6 · The paper itself

Abstract

rationalePostsynaptic density-95 (PSD95) is a scaffolding protein that associates with voltage-gated, Shaker-type K(+) (KV1) channels and promotes the expression of KV1 channels in vascular smooth muscle cells of the cerebral (cVSMCs) circulation. However, the physiological role of PSD95 in mediating molecular signaling in cVSMCs is unknown.

objectiveWe explored whether a specific interaction between PSD95 and KV1 channels enables protein kinase A phosphorylation of KV1 channels in cVSMCs to promote vasodilation. METHODS AND

resultsRat cerebral arteries were used for analyses. A membrane-permeable peptide (KV1-C peptide) corresponding to the postsynaptic density-95, discs large, zonula occludens-1 binding motif in the C terminus of KV1.2α was designed as a dominant-negative peptide to disrupt the association of KV1 channels with PSD95. Application of KV1-C peptide to cannulated, pressurized cerebral arteries rapidly induced vasoconstriction and depolarized cVSMCs. These events corresponded to reduced coimmunoprecipitation of the PSD95 and KV1 proteins without altering surface expression. Middle cerebral arterioles imaged in situ through cranial window also constricted rapidly in response to local application of KV1-C peptide. Patch-clamp recordings confirmed that KV1-C peptide attenuates KV1 channel blocker (5-(4-phenylalkoxypsoralen))-sensitive current in cVSMCs. Western blots using a phospho-protein kinase A substrate antibody revealed that cerebral arteries exposed to KV1-C peptide showed markedly less phosphorylation of KV1.2α subunits. Finally, phosphatase inhibitors blunted both KV1-C peptide-mediated and protein kinase A inhibitor peptide-mediated vasoconstriction.

conclusionsThese findings provide initial evidence that protein kinase A phosphorylation of KV1 channels is enabled by a dynamic association with PSD95 in cerebral arteries and suggest that a disruption of such association may compromise cerebral vasodilation and blood flow.

Indexed as

AnimalsCerebral ArteriesCyclic AMP-Dependent Protein KinasesDisks Large Homolog 4 ProteinEnzyme InhibitorsIntracellular Signaling Peptides and ProteinsMaleMembrane PotentialsMembrane ProteinsModels, AnimalPatch-Clamp TechniquesPhosphorylationRatsRats, Sprague-DawleyRegional Blood FlowShaker Superfamily of Potassium ChannelsCyclic AMP-Dependent Protein KinasesDisks Large Homolog 4 ProteinDlg4 protein, ratEnzyme InhibitorsIntracellular Signaling Peptides and ProteinsMembrane ProteinsShaker Superfamily of Potassium Channelscerebral arteriesmuscle, smooth, vascularPDZ domainspotassium channels

Identifiers

PMID24585759
PMCPMC4049098
OpenAlexW2151821732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.